UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: ~~March~~June 3130, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission file number: 001-40991

BLUE STAR FOODS CORP.

(Exact name of registrant as specified in its charter)

Delaware

82-4270040

(State or other jurisdiction of

incorporation or organization)

(IRS Employer

Identification No.)

3000 NW 109th Avenue

Miami, Florida 33172

(Address of principal executive offices)

(305) 836-6858

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value		BSFC		Over The Counter Markets Group

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~July~~August 14, 2025, there were 1617,~~829~~561,~~468~~862 shares of the registrant’s common stock outstanding.

BLUE STAR FOODS CORP.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED ~~MARCH~~JUNE 3130, 2025

TABLE OF CONTENTS

		PAGE
PART I - FINANCIAL INFORMATION		4
Item 1.	Financial Statements (Unaudited)	4
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3031
Item 4.	Controls and Procedures	3031
PART II - OTHER INFORMATION		3132
Item 1.	Legal Proceedings	3132
Item 1A.	Risk Factors	3132
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3132
Item 3.	Defaults Upon Senior Securities	3132
Item 4.	Mine Safety Disclosures	3132
Item 5.	Other Information	3132

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Except for historical information, this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such forward-looking statements include, among others, those statements including the words “believes”, “anticipates”, “expects”, “intends”, “estimates”, “plans” and words of similar import. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Forward-looking statements are based on our current expectations and assumptions regarding our business, potential target businesses, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore that you should not rely on any of these forward-looking statements as statements of historical fact or as guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include changes in local, regional, national or global political, economic, business, competitive, market (supply and demand), regulatory conditions and the following:

	●	Our ability to raise capital when needed and on acceptable terms and conditions;

	●	Our ability to make acquisitions and integrate acquired businesses into our company;

	●	Our ability to attract and retain management with experience in the business of importing, packaging and selling of seafood;

	●	Our ability to negotiate, finalize and maintain economically feasible agreements with suppliers and customers;

	●	The availability of crab meat and other premium seafood products we sell;

	●	The intensity of competition; and

	●	Changes in the political and regulatory environment and in business and fiscal conditions in the United States and overseas.

A description of these and other risks and uncertainties that could affect our business appears in the section captioned “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 which we filed with the Securities and Exchange Commission (“SEC”) on June 23, 2025. The risks and uncertainties described under “Risk Factors” are not exhaustive.

Given these uncertainties, readers of this Quarterly Report on Form 10-Q (“Quarterly Report”) are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future events or developments.

All references in this Quarterly Report to the “Company”, “we”, “us”, or “our”, are to Blue Star Foods Corp., a Delaware corporation, and its consolidated subsidiaries, John Keeler & Co., Inc., d/b/a Blue Star Foods, a Florida corporation (“Keeler & Co.”), and its wholly-owned subsidiary, Coastal Pride Seafood, LLC, a Florida limited liability company (“Coastal Pride”), Taste of BC Aquafarms, Inc., a corporation formed under the laws of the Province of British Columbia, Canada (“TOBC”) and Afritex Ventures, Inc., a Florida corporation (“AFVFL”).

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States and the rules of the SEC, and should be read in conjunction with the audited financial statements and notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2024. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the periods presented have been reflected herein. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year.

Blue Star Foods Corp.

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

	MARCH 31, 2025			DECEMBER 31, 2024
	JUNE 30, 2025			DECEMBER 31, 2024
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	2345,~~049~~976		$	326,854
Accounts receivable, net of allowances and credit losses of $30,473 and $33,880		455,518			349,641
Accounts receivable, net of allowances and credit losses of $28,839 and $33,880		344,309			349,641
Inventory, net		~~342~~248,~~825~~995			447,760
Other current assets		~~932~~455,~~810~~006			1,109,494
Total Current Assets		1,754,202			2,233,749
Advance to related party		110,266			-
FIXED ASSETS, net		126,389			122,860
Total Current Assets		1,204,552			2,233,749
RIGHT OF USE ASSET		74,599			84,145
FIXED ASSETS, net		119,878			122,860
OTHER ASSETS		95,328			113,845
RIGHT OF USE ASSET-RELATED PARTY		69,114			84,145
TOTAL ASSETS	$	2,050,518		$	2,554,599
OTHER ASSETS		78,297			113,845
TOTAL ASSETS	$	1,471,841		$	2,554,599
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable and accruals	$	963,428		$	982,243
Accounts payable	$	599,824		$	307,121
Customer refunds		23,510			56,899
Accrued expenses		281,532			135,122
Current maturities of lease liabilities		36,035			35,688
Accrued compensation		270,000			540,000
Loan payable		592,194			729,698
Customer refunds		33,855			56,899
Derivative liability		35,475			49,565
Current maturities of lease liabilities – related party		38,553			35,688
Loan payable		723,899			729,698
Derivative liability		19,629			49,565
Other current liabilities		790,881			790,881
Total Current Liabilities		2,~~441~~758,~~523~~173			2,644,974
LONG-TERM LIABILITIES
Lease liability, net of current portion		38,564			48,457
Lease liability, net of current portion – related party		30,561			48,457
Debt, net of current portion and discounts		~~208~~48,~~074~~509			52,865
TOTAL LIABILITIES		2,~~688~~837,~~161~~243			2,746,296
STOCKHOLDERS’ EQUITY
Series A 8% cumulative convertible preferred stock, $0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of March 31, 2025, and 0 shares issued and outstanding as of December 31, 2024		-			-
Series A 8% cumulative convertible preferred stock, $0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of June 30, 2025, and 0 shares issued and outstanding as of December 31, 2024		-			-
Common stock, $0.0001 par value, 100,000,000 shares authorized; 16,254,721 shares issued and outstanding as of March 31, 2025, and 9,837,374 shares issued and outstanding as of December 31, 2024		1,616			974
Common stock, $0.0001 par value, 100,000,000 shares authorized; 16,829,468 shares issued and outstanding as of June 30, 2025, and 9,837,374 shares issued and outstanding as of December 31, 2024		1,673			974
Additional paid-in capital		46,~~902~~938,~~199~~289			46,167,697
Accumulated other comprehensive income		24,014			5,174
Accumulated other comprehensive loss		(88,074	)		5,174
Accumulated deficit		(4748,~~489~~140,~~149~~967	)		(46,289,219	)
Treasury stock, 151 shares as of March 31, 2025 and 151 shares as of December 31, 2024		(76,323	)		(76,323	)
Treasury stock, 151 shares as of June 30, 2025 and 151 shares as of December 31, 2024		(76,323	)		(76,323	)
TOTAL STOCKHOLDERS’ EQUITY		(~~637~~1,~~643~~365,402	)		(191,697	)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	21,~~050~~471,~~518~~841		$	2,554,599

The accompanying notes are an integral part of these unaudited consolidated financial statements

Blue Star Foods Corp.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

	Three Months Ended March 31
	2025			2024			2025			2024
	2025			2024
	Three months ended June 30						Six months ended June 30
REVENUE, NET	$	960,758		$	1,059,355
	2025			2024			2025			2024
COST OF REVENUE		869,114			1,098,989
REVENUE, NET	$	1,172,340		$	635,018		$	2,133,098		$	1,694,373
GROSS PROFIT		91,644			(39,634	)
COST OF REVENUE		919,650			587,516			1,788,764			1,686,505
COMMISSIONS		-			4,221
GROSS PROFIT		252,690			47,502			344,334			7,868
SALARIES AND WAGES		408,296			301,790
COMMISSIONS		460			-			460			4,221
DEPRECIATION AND AMORTIZATION		6,386			1,299
SALARIES AND WAGES		333,226			291,231			603,510			598,912
OTHER OPERATING EXPENSES		648,483			681,611
DIRECTORS COMPENSATION		138,012			4,217			276,024			(1,673	)
LOSS FROM OPERATIONS		(971,521	)		(1,028,555	)
DEPRECIATION AND AMORTIZATION		6,932			1,377			13,318			2,676
OTHER INCOME		6,615			1,535
OTHER OPERATING EXPENSES [1]		267,935			634,190			916,418			1,315,801
CHANGE IN FAIR VALUE OF DERIVATIVE AND WARRANT LIABILITIES		14,090			82,636
LOSS FROM OPERATIONS		(493,875	)		(883,513	)		(1,465,396	)		(1,912,069	)
LOSS ON SETTLEMENT OF DEBT		(41,066	)		-
OTHER INCOME (LOSS)		(1,866	)		48,127			4,749			49,662
INTEREST EXPENSE		(208,048	)		(335,067	)
LOSS ON SETTLEMENT OF DEBT		-			-			(41,066	)		-
NET LOSS		(1,199,930	)		(1,279,451	)
CHANGE IN FAIR VALUE OF DERIVATIVE AND WARRANT LIABILITIES		15,846			(327,122	)		29,936			(244,486	)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$	(1,199,930	)	$	(1,279,451	)
INTEREST EXPENSE		(171,923	)		(871,249	)		(379,971	)		(1,206,316	)
COMPREHENSIVE GAIN (LOSS):
NET LOSS		(651,818	)		(2,033,757	)		(1,851,748	)		(3,313,209	)
CHANGE IN FOREIGN CURRENCY TRANSLATION ADJUSTMENT		18,840			78,033
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	$	(651,818	)	$	(2,033,757	)	$	(1,851,748	)	$	(3,313,209	)
COMPREHENSIVE GAIN (LOSS)		(1,181,090	)		(1,201,418	)
COMPREHENSIVE LOSS:
Loss per common share:
CHANGE IN FOREIGN CURRENCY TRANSLATION ADJUSTMENT		(112,088	)		18,789			(93,248	)		96,822
Net loss per common share - basic and diluted	$	(0.08	)	$	(2.42	)
		.
Weighted average common shares outstanding - basic and diluted		14,452,810			527,750
COMPREHENSIVE LOSS	$	(763,906	)	$	(2,014,968	)	$	(1,944,996	)	$	(3,216,387	)
Loss per common share:
Net loss per common share - basis and diluted	$	(0.04	)	$	(1.68	)	$	(0.12	)	$	(3.82	)
Weighted average common shares outstanding - basic and diluted		16,640,461			1,209,792			15,552,678			866,510

The accompanying notes are an integral part of these unaudited consolidated financial statements

[1]	Includes $22,900 and $26,700 from a related party for the six months ended June 30, 2025 and 2024, respectively.

Blue Star Foods Corp.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) (UNAUDITED)

~~THREE~~SIX MONTHS ENDED ~~MARCH~~JUNE 3130, 2025 AND 2024

	Series A Preferred Stock $.0001 par value				Common Stock $.0001 par value
	Shares		Amount		Shares		Amount		Additional Paid-in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income (Loss)			Treasury Stock			Total Stockholders’ Equity
December 31, 2024		-	$	-		9,837,374	$	974	$	46,167,697		$	(46,289,219	)	$	5,174		$	(76,323	)	$	(191,697	)
Stock based compensation		-		-		-		-		(5,627	)		-			-			-			(5,627	)
Common stock issued for service		-		-		4,622,762		462		572,538			-			-			-			573,000
Common stock issued for note payment		-		-		1,444,585		145		147,676			-			-			-			147,821
Common stock issued for cash						350,000		35		19,915			-			-			-			19,950
Net Loss		-		-		-		-		-			(1,199,930	)		-			-			(1,199,930	)
Cumulative translation adjustment		-		-		-		-		-			-			18,840			-			18,840
March 31, 2025		-	$	-		16,254,721		1,616		46,902,199			(47,489,149	)		24,014			(76,323	)	$	(637,643	)
Stock based compensation		-		-		-		-		3,147			-			-			-			3,147
Common stock issued for service		-		-		574,747		57		32,943			-			-			-			33,000
Net Loss		-		-		-		-		-			(651,818	)		-			-			(651,818	)
Cumulative translation adjustment		-		-		-		-		-			-			(112,088	)		-			(112,088	)
June 30, 2025		-	$	-		16,829,468		1,673		46,938,289			(48,140,967	)		(88,074	)		(76,323	)	$	(1,365,402	)

	Series A Preferred Stock $.0001 par value				Common Stock $.0001 par value
	Shares		Amount		Shares		Amount		Additional Paid-in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income (Loss)			Treasury Stock			Total Stockholders’ Equity (Deficit)
December 31, 2023		-	$	-		461,722	$	46	$	36,661,926		$	(33,810,732	)	$	(179,995	)	$	(76,323	)	$	2,594,922
Balance		-	$	-		461,722	$	46	$	36,661,926		$	(33,810,732	)	$	(179,995	)	$	(76,323	)	$	2,594,922
Stock based compensation		-		-		-		-		8,800			-			-			-			8,800
Common stock issued for service		-		-		5,238		1		32,999			-			-			-			33,000
Common stock issued for note payment		-		-		15,000		2		68,318			-			-			-			68,320
Common stock issued for cash						226,656		23		836,337			-			-			-			836,360
Common stock issued for loan commitment fees		-		-		7,092		1		49,999			-			-			-			50,000
Net Loss		-		-		-		-		-			(1,279,451	)		-			-			(1,279,451	)
Cumulative translation adjustment		-		-		-		-		-			-			78,033			-			78,033
March 31, 2024		-	$	-		715,708	$	73	$	37,658,379		$	(35,090,183	)	$	(101,962	)	$	(76,323	)	$	2,389,984
Balance		-	$	-		715,708	$	73	$	37,658,379		$	(35,090,183	)	$	(101,962	)	$	(76,323	)	$	2,389,984
Stock based compensation		-		-		-		-		(14,423	)		-			-			-			(14,423	)
Common stock issued for service		-		-		6,319		2		21,998			-			-			-			22,000
Common stock issued for note payment		-		-		426,831		43		1,684,707			-			-			-			1,684,750
Common stock issued for cash		-		-		1,113,000		113		2,145,942			-			-			-			2,146,055
Common stock issued for loan commitment fees		-		-		10,000		1		23,299			-			-			-			23,300
Net Loss		-		-		-		-		-			(2,033,757	)		-			-			(2,033,757	)
Cumulative translation adjustment		-		-		-		-		-			-			18,789			-			18,789
June 30, 2024		-	$	-		2,271,858	$	232	$	41,519,902		$	(37,123,940	)	$	(83,173	)	$	(76,323	)	$	4,236,698
Balance		-	$	-		2,271,858	$	232	$	41,519,902		$	(37,123,940	)	$	(83,173	)	$	(76,323	)	$	4,236,698

The accompanying notes are an integral part of these unaudited consolidated financial statements

Blue Star Foods Corp.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Three Months Ended March 31
	2025			2024
	Six Months Ended June 30
	2025			2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$	(1,~~199~~851,~~930~~748	)	$	(13,~~279~~313,~~451~~209	)
Adjustments to reconcile net loss to net cash (used in) operating activities:
Stock based compensation		(52,~~627~~480	)		8(5,~~800~~623	)
Common stock issued for service		3366,000			3355,000
Depreciation of fixed assets		613,~~386~~318			12,~~299~~676
Amortization of debt discounts		94152,~~009~~047			~~113~~777,~~352~~663
Allowance for inventory obsolescence		~~(18~~27,~~378~~432	)		~~160~~370,~~049~~923
Loss on settlement of debt		40,166			-
Lease expense		915,~~546~~031			1020,~~207~~226
Credit loss expense		(810,~~407~~041	)		-
Gain on revaluation of fair value of derivative and warrant liabilities		(14,090	)		(82,636	)
(Gain) Loss on revaluation of fair value of derivative and warrant liabilities		(29,936	)		244,486
Changes in operating assets and liabilities:
Accounts receivables		~~(97~~15,~~469~~373	)		~~114~~334,~~130~~550
Inventories		~~123~~171,~~313~~333			~~694~~593,~~321~~306
Advances to related parties		-			95,525
Other current assets		~~176~~544,~~682~~222			(~~446~~1,~~138~~524,042	)
Right of use liability		(915,~~546~~031	)		(1020,~~207~~226	)
Other assets		(20,000	)		6(25,~~254~~835	)
Accounts payable and accruals		531,184			(98,433	)
Accounts payable		302,703			(279,651	)
Customer refunds		(33,389	)		-
Accrued expenses		146,410			117,542
Net Cash (Used in) Operating Activities		(392,550	)		(679,928	)
Accrued compensation		270,000			-
Customer refunds		(23,044	)		(82,388	)
Net Cash (Used in) Operating Activities		(188,245	)		(2,639,077	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of fixed assets		(9,914	)		(2357,~~146~~797	)
Net Cash (Used in) Investing Activities		(9,914	)		(2357,~~146~~797	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from common stock offering		19,950			~~446~~2,~~360~~160,765
Proceeds from short-term loan		550,000			~~532~~1,357,491
Repayments of short-term loan		(~~489~~560,~~783~~788	)		(~~276~~746,~~643~~626	)
Repayments of related party notes payable		-			(79121,582	)
Net Cash Provided by Financing Activities		809,~~167~~162			~~622~~2,~~626~~650,048
Effect of Exchange Rate Changes on Cash		18(91,~~492~~881	)		7895,~~583~~773
NET INCREASE IN CASH AND CASH EQUIVALENTS		(303,805	)		(1,865	)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(280,878	)		48,947
CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD		326,854			24,163
CASH AND CASH EQUIVALENTS – END OF PERIOD	$	2345,~~049~~976		$	2273,~~298~~110
Supplemental Disclosure of Cash Flow Information
Cash paid for interest	$	25113,~~472~~729		$	~~234~~311,~~051~~075
SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES
Common stock issued for partial settlement of note payable		147,821			681,~~320~~753,070
Common stock issued for loan commitment fees		-			5073,~~000~~300
Common stock issued for directors stock compensation		540,000			-
Common stock issued for accrued directors stock compensation		540,000			-

The accompanying notes are an integral part of these unaudited consolidated financial statements

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Company Overview

Blue Star Foods Corp., a Delaware corporation (“we”, “our”, the “Company”), is an international sustainable marine protein company based in Miami, Florida that imports, packages and sells refrigerated pasteurized crab meat, and other premium seafood products. The Company’s main operating business, John Keeler & Co., Inc. (“Keeler & Co.”) was incorporated in the State of Florida in May 1995. The Company has three other subsidiaries, Coastal Pride, TOBC and AFVFL which maintain the Company’s fresh crab meat, steelhead salmon and packaged seafood and other inventory businesses, respectively. The Company’s current source of revenue is importing blue and red swimming crab meat primarily from South East Asia and distributing it in the United States and Canada under several brand names such as Blue Star, Oceanica, Pacifika, Crab & Go, First Choice, Good Stuff and Coastal Pride Fresh, and steelhead salmon and rainbow trout fingerlings produced under the brand name Little Cedar Farms for distribution in

Canada.

On February 3, 2022, Coastal Pride entered into an asset purchase agreement with Gault Seafood, LLC, a South Carolina limited liability company (“Gault Seafood”), and Robert J. Gault II, President of Gault Seafood (“Gault”) pursuant to which Coastal Pride acquired all of the Seller’s right, title and interest in and to assets relating to Gault Seafood’s soft-shell crab operations, including intellectual property, equipment, vehicles and other assets used in connection with the soft-shell crab business. Coastal Pride did not assume any liabilities in connection with the acquisition. The purchase price for the assets consisted of a cash payment in the amount of $359,250 and the issuance of 8,355 shares of common stock of the Company with a fair value of $359,250. Such shares were subject to a leak-out agreement pursuant to which Gault Seafood could not sell or otherwise transfer the shares until February 3, 2023.

On February 1, 2024, the Company entered into a ninety-day Master Services Agreement (the “Services Agreement”) with Afritex Ventures, Inc. a Texas corporation (“Afritex”), pursuant to which the Company will be responsible for all of Afritex’s operations and finance functions. The Company will provide Afritex with working capital in order to sustain operations and will purchase certain inventory listed in the Services Agreement. In consideration for its services, during the term of the Services Agreement, the Company will earn all of the revenue and profits by the purchase and sale of Afritex’s inventory. Under the Services Agreement, Afritex may not sell or otherwise use as consideration any of its intellectual property without the Company’s consent. The Company must maintain certain commercial liability insurance during the term of the Services Agreement. The Services Agreement also provides that the Company may not solicit Afritex employees for 24 months nor circumvent existing business relationships of Afritex for three years, after the term of the Services Agreement. The term of the Services Agreement will automatically extend for three thirty-day periods, if Afritex’s outstanding debt is no greater than $325,000. The Company automatically extended the Service Agreement to August 31, 2024 after which it expired. The Company incurred losses of approximately $1.5 million from our Services Agreement with Afritex.

In connection with the Services Agreement, on February 12, 2024, the Company entered into an Intangibles Assets and Machinery Option to Purchase Agreement with Afritex (the “Option Agreement”). Pursuant to the Option Agreement, the Company has the option to purchase Afritex’s intangible assets, machinery and equipment set forth in the Option Agreement for a purchase price of $554,714 for machinery and equipment and 100,000 shares of the Company’s common stock were issued on February 12, 2024 to be held in escrow, for intangible assets. The Company did not exercise its option to purchase such intangible assets, machinery and equipment.

In connection with the Services Agreement, on February 1, 2024, AFVFL, a wholly-owned subsidiary of the Company, was incorporated in the State of Florida for the purpose of purchasing raw materials from Afritex for the preparation of packaged seafood and other inventory to be sold to various customers in the United States.

On May 20, 2024, the Company amended its Certificate of Incorporation to affect a one-for-fifty reverse stock split (“Reverse Stock Split”), which became effective the same day. All share and per share amounts have been restated for all periods presented to reflect the Reverse Stock Split.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The following unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, such interim financial statements do not include all the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete annual financial statements. The information furnished reflects all adjustments, consisting only of normal recurring items which are, in the opinion of management, necessary in order to make the financial statements not misleading. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The consolidated balance sheet as of December 31, 2024 has been derived from the Company’s annual financial statements that were audited by our independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto which are included in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on June 23, 2025 for a broader discussion of our business and the risks inherent in such business.

Advances to Suppliers and Related Party

In the normal course of business, the Company may advance payments to its suppliers, including of Bacolod Blue Star Export Corp. (“Bacolod”), a related party based in the Philippines. These advances are in the form of prepayments for products that will ship within a short window of time. In the event that it becomes necessary for the Company to return products or adjust for quality issues, the Company is issued a credit by the vendor in the normal course of business and these credits are also reflected against future shipments.

As of ~~March~~June 3130, 2025, and December 31, 2024, the balance due from the related party for future shipments was approximately $1,300,000. During the year ended December 31, 2024, the Company determined it was appropriate to record an allowance for the full balance due from Bacolod. No new purchases have been made from Bacolod since November 2020. There was no cost of revenue related to inventories purchased from Bacolod recorded for the ~~three~~six months ended ~~March~~June 3130, 2025 and 2024.

As of June 30, 2025, the Company made payments to John Keeler for an unsecured promissory note which has already been paid off in the year 2024. These payments exceeded the amount owed under the note, resulting in an overpayment of approximately $110,000 as advance to related party. Management is evaluating the appropriate method for recovery or settlement of the overpaid amount.

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, as such, we record revenue when our customer obtains control of the promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. The Company’s source of revenue is from importing blue and red swimming crab meat primarily from South East Asia and distributing it in the United States and Canada under several brand names such as Blue Star, Oceanica, Pacifika, Crab & Go, First Choice, Good Stuff and Coastal Pride Fresh, and steelhead salmon and rainbow trout fingerlings produced under the brand name Little Cedar Farms for distribution in Canada. We sell primarily to food service distributors. The Company also sells its products to wholesalers, retail establishments and seafood distributors.

To determine revenue recognition for the arrangements that the Company determines are within the scope of Topic 606, the Company performs the following five steps: (1) identify the contract(s) with a customer by receipt of purchase orders and confirmations sent by the Company which includes a required line of credit approval process, (2) identify the performance obligations in the contract which includes shipment of goods to the customer FOB shipping point or destination, (3) determine the transaction price which initiates with the purchase order received from the customer and confirmation sent by the Company and will include discounts and allowances by customer if any, (4) allocate the transaction price to the performance obligations in the contract which is the shipment of the goods to the customer and transaction price determined in step 3 above and (5) recognize revenue when (or as) the entity satisfies a performance obligation which is when the Company transfers control of the goods to the customers by shipment or delivery of the products.

The Company elected an accounting policy to treat shipping and handling activities as fulfillment activities. Consideration payable to a customer is recorded as a reduction of the arrangement’s transaction price, thereby reducing the amount of revenue recognized, unless the payment is for distinct goods or services received from the customer.

Accounts Receivable

Accounts receivable consist of unsecured obligations due from customers under normal trade terms, usually net 30 days. The Company grants credit to its customers based on the Company’s evaluation of a particular customer’s credit worthiness.

Allowances for credit losses are maintained for potential credit losses based on the age of the accounts receivable and the results of the Company’s periodic credit evaluations of its customers’ financial condition. Receivables are written off as uncollectible and deducted from the allowance for doubtful accounts after collection efforts have been deemed to be unsuccessful. Subsequent recoveries are netted against the allowance for credit losses. The Company generally does not charge interest on receivables.

Receivables are net of estimated allowances for doubtful accounts and sales return, allowances and discounts. They are stated at estimated net realizable value. As of ~~March~~June 3130, 2025, the Company recorded allowances for sales returns, allowances and discounts of $3028,~~000~~800 and refund liability of $2333,~~500~~800. There was no allowance for bad debt recorded for the ~~three~~six months ended ~~March~~June 3130, 2025. As of December 31, 2024, the Company recorded sales return, allowances and discounts of $39,000 and refund liability of $57,000. There was no allowance for bad debt recorded for the year ended December 31, 2024.

Inventories

Substantially all of the Company’s inventory consists of packaged crab meat located at a public cold storage facility and merchandise in transit from suppliers. The Company also has eggs and fish in process inventory from TOBC and raw materials for packaged seafood and other inventory from AFVFL. The cost of inventory is primarily determined using the specific identification method for crab meat and raw materials for packaged seafood inventory. Fish in process inventory is measured based on the estimated biomass of fish on hand. The Company has established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques. Inventory is valued at the lower of cost or net realizable value, cost being determined using the first-in, first-out method for crab meat and raw materials for packaged seafood inventory and using various estimates and assumptions in regard to the calculation of the biomass, including expected yield, market value of the biomass, and estimated costs of completion.

Merchandise is purchased on a cost and freight shipping point basis, and it becomes the Company’s asset and liability upon leaving the suppliers’ warehouse.

The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company recorded an inventory allowance of $1,~~398~~444,~~927~~737. For the year ended December 31, 2024, the Company recorded an inventory allowance in the amount of $1,417,305 which was charged to cost of goods sold.

The Company’s inventory as of ~~March~~June 3130, 2025 and December 31, 2024 consists of:

Schedule of Inventory

	March 31, 2025			December 31, 2024
	June 30, 2025			December 31, 2024
Inventory purchased for resale	$	1,~~640~~639,~~581~~247		$	1,644,085
Feeds and eggs processed		6923,~~223~~180			65,924
Raw materials for packaged seafood		31,~~948~~305			155,056
Less: Inventory allowance		(1,~~398~~444,~~927~~737	)		(1,417,305	)
Inventory, net	$	~~342~~248,~~825~~995		$	447,760

Lease Accounting

The Company accounts for its leases under ASC 842, Leases, which requires all leases to be reported on the balance sheet as right-of-use assets and lease obligations. The Company elected the practical expedients permitted under the transition guidance that retained the lease classification and initial direct costs for any leases that existed prior to adoption of the standard.

The Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are ~~generally~~ generally those leases that would allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property and equipment, net. All other leases are categorized as operating leases. The Company did not have any finance leases as of ~~March~~June 3130, 2025. The Company’s leases generally have terms that range from three years for equipment and ~~six6~~6 six to seven years for real property. The Company elected the accounting policy to include both the lease and non-lease components of its agreements as a single component and accounts for them as a lease.

Lease liabilities are recognized at the present value of the fixed lease payments using a discount rate based on similarly secured borrowings available to us. Lease assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the lease. Lease assets are tested for impairment in the same manner as long-lived assets used in operations. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.

When we have the option to extend the lease term, terminate the lease before the contractual expiration date, or purchase the leased asset, and it is reasonably certain that we will exercise the option, we consider these options in determining the classification and measurement of the lease. Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.

Long-lived Assets

Management reviews long-lived assets, including finite-lived intangible assets, for indicators of impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Cash flows expected to be generated by the related assets are estimated over the asset’s useful life on an undiscounted basis. If the evaluation indicates that the carrying value of the asset may not be recoverable, the potential impairment is measured using fair value. Fair value estimates are completed using a discounted cash flow analysis. Impairment losses for assets to be disposed of, if any, are based on the estimated proceeds to be received, less costs of disposal. No impairment was recognized for the ~~three~~six months ended ~~March~~June 3130, 2025 and for the year ended December 31, 2024.

Foreign Currency Exchange Rates Risk

The Company manages its exposure to fluctuations in foreign currency exchange rates through its normal operating activities. Its primary focus is to monitor exposure to, and manage, the economic foreign currency exchange risks faced by, its operations and realized when the Company exchanges one currency for another. The Company’s operations primarily utilize the U.S. dollar and Canadian dollar as its functional currencies. Movements in foreign currency exchange rates affect its financial statements.

Fair Value Measurements and Financial Instruments

Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and is measured using inputs in one of the following three categories:

Level 1 measurements are based on unadjusted quoted prices in active markets for identical assets or liabilities that we have the ability to access. Valuation of these items does not entail a significant amount of judgment.

Level 2 measurements are based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active or market data other than quoted prices that are observable for the assets or liabilities.

Level 3 measurements are based on unobservable data that are supported by little or no market activity and are significant to the fair value of the assets or liabilities.

Our financial instruments include cash, accounts receivable, accounts payable, accrued expenses, debt obligations, derivative liabilities and warrant liabilities. We believe the carrying values of our cash, accounts receivable, accounts payable, and accrued expenses approximate their fair values because they are short term in nature or payable on demand. The derivative liability is the embedded conversion feature on the 2023 Lind convertible note. All derivatives and warrant liabilities are recorded at fair value. The change in fair value for derivatives and warrants liabilities is recognized in earnings. The Company’s derivative and warrant liabilities are measured at fair value on a recurring basis using the Black Scholes Pricing model as of ~~March~~June 3130, 2025 and December 31, 2024. There were no financial assets and liabilities that were measured at fair value on a recurring basis under Levels 1 and 2.

	Level 3 Fair Value
	As of March 31, 2025		As of December 31, 2024
	As of June 30, 2025		As of December 31, 2024
Liabilities
Derivative liability on convertible debt	$	3519,~~475~~629	$	49,565
Total	$	3519,~~475~~629	$	49,565

The table below presents the change in the fair value of the derivative liability convertible debt and warrant liability during the ~~three~~ six months ended ~~March~~June 3130, ~~2025~~2024:

Derivative liability balance, January 1, 2025	$	49,565
Derivative liability balance, January 1, 2024	$	1,047,049
Issuance of derivative liability during the period		-
Change in derivative liability during the period		(14,090	)
Settlement of derivative liability		(808,209	)
Derivative liability balance, March 31, 2025	$	35,475
Change in fair value of derivative liability during the period		245,510
Derivative liability balance, June 30, 2024	$	484,350
Warrant liability balance, January 1, 2024	$	1,574
Issuance of warrant liability during the period		-
Change in fair value of warrant liability during the period		(1,024	)
Warrant liability balance, June 30, 2024	$	550

The table below presents the change in the fair value of the derivative liability convertible debt and warrant liability during the six months ended June 30, 2025:

Derivative liability balance, January 1, 2025	$	49,565
Issuance of derivative liability during the period		-
Change in derivative liability during the period		(14,090	)
Derivative liability balance, March 31, 2025	$	35,475
Issuance of derivative liability during the period		-
Change in derivative liability during the period		(15,846	)
Derivative liability balance, June 30, 2025	$	19,629

The fair market value of all derivatives and warrant liability as of December 31, 2024 was determined using the Black-Scholes option pricing model which used the following assumptions:

Stock price	$	0.13
Expected dividend yield		0.00	%
Expected stock price volatility		189.14	%
Risk-free interest rate		4.32	%
Expected term		0.58 years

The fair market value of all derivatives and warrant liability as of ~~March~~June 3130, 2025 was determined using the Black-Scholes option pricing model which used the following assumptions:

Stock price	$	0.0506
Expected dividend yield		0.00	%
Expected stock price volatility		~~189~~133.2770	%
Risk-free interest rate		4.3228	%
Expected term		0.3308 years

Segment Information

The Company’s business consists of one operating segment, which is also its one reportable segment. The Company derives revenue by providing sales of primarily seafood products to customers. The Company’s CODM is its chief executive officer who reviews financial information presented on a consolidated basis. The CODM reviews total assets in the consolidated balance sheets and net loss and its components in the consolidated statement of operations such as, cost of goods sold and other operating expenses, to assess financial performance and allocate resources.

Reclassification of Prior Year Presentation

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

Recent Accounting Pronouncements

ASU 2023-09 – Income Taxes (Topic 740)

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU aims to enhance the transparency and usefulness of income tax disclosures by requiring public business entities to provide more disaggregated information in the effective tax rate reconciliation and for income taxes paid. Key provisions include a requirement for tabular reconciliation using both percentages and amounts, broken out into specific categories, with certain reconciling items at or above a 5% quantitative threshold further disaggregated by nature and/or jurisdiction. Additionally, the ASU requires disclosure of income taxes paid (net of refunds received), disaggregated by federal, state/local, and foreign jurisdictions, and amounts paid to individual jurisdictions that comprise 5% or more of total income taxes paid. The ASU also eliminates certain existing disclosure requirements related to unrecognized tax benefits and cumulative unrecognized deferred tax liabilities. For public business entities, the amendments in ASU 2023-09 are effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and related disclosures. The Company does not expect this adoption to have a material impact on its consolidated financial statements.

ASU 2024-03 – Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This ASU requires public business entities to disclose more detailed information about certain costs and expenses in the notes to their financial statements, both in annual and interim filings. The objective is to provide investors with greater transparency into a company’s expense structure, enabling a better understanding of performance, assessment of future cash flows, and comparison with other entities. Key provisions include the disaggregation, in a tabular format, of specific natural expense categories such as purchases of inventory, employee compensation, depreciation, and intangible asset amortization, within each relevant expense caption on the income statement. The ASU also requires disclosure of the total amount of selling expenses and a qualitative description of expenses remaining in the “other” category. For public business entities, the amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact of adopting this ASU on its financial statements and disclosures.

Note 3. Going Concern

The accompanying consolidated financial statements and notes have been prepared assuming the Company will continue as a going concern. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company incurred a net loss of $1,~~199~~851,~~930~~748, had an accumulated deficit of $4748,~~489~~140,~~149~~967 and a ~~working~~ working capital deficit of $~~687~~1,~~321~~553,621. These factors raise substantial doubt as to the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company’s ability to increase revenues, execute on its business plan to acquire complimentary companies, raise capital, and to continue to sustain adequate working capital to finance its operations. The failure to achieve the necessary levels of profitability and cash flows would be detrimental to the Company. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note 4. Other Current Assets

Other current assets totaled $~~932~~565,~~810~~ 272 as of ~~March~~June 3130, 2025 and $1,109,494 as of December 31, 2024. As of ~~March~~June 3130, 2025, approximately ~~$731,000~~ ~~and~~ $84301,000 of the balance was related to prepaid inventory to the Company’s suppliers ~~and prepaid legal fees, respectively~~. As of December 31, 2024, approximately $943,000 and $136,000 of the balance was related to prepaid inventory to the Company’s suppliers and prepaid legal fees, respectively. The remainder of the balance was related to prepaid insurance and other prepaid expenses.

Note 5. Fixed Assets, Net

Fixed assets comprised the following:

Schedule of Fixed Assets

	March 31, 2025			December 31, 2024
	June 30, 2025			December 31, 2024
Computer equipment	$	56,746		$	55,346
RAS system		8,~~515~~390			-
Automobiles		94,298			94,298
Leasehold improvements		17,904			17,904
Total		177,~~463~~338			167,548
Fixed assets, gross		177,~~463~~338			167,548
Less: Accumulated depreciation		(5157,~~074~~460	)		(44,688	)
Fixed assets, net	$	~~126~~119,~~389~~878		$	122,860

For the ~~three~~six months ended ~~March~~June 3130, 2025 and 2024, depreciation expense totaled approximately $613,~~400~~300 and $12,~~300~~600, respectively.

Note 6. ~~Debt~~Accrued Compensation

Accrued compensation totaled $270,000 as of June 30, 2025 and $540,000 as of December 31, 2024. As of June 30, 2025, the total balance was related to accruing compensation for year-end payment to the Company’s Board of Directors. This is a fixed dollar amount compensation and will be settled by common stock calculated at year-end. This was recorded in the directors compensation on the income statement with directors option expenses as non-cash compensation. During six months ended June 30, 2024, there is no compensation granted to directors as the Company granted the annual compensation at the end of year 2024 and the Company recognized a net credit to stock compensation expense of $1,673 due to options forfeitures.

Note 7. Debt

John Keeler Promissory Notes

The Company had unsecured promissory notes outstanding to John Keeler, a related party, of approximately $0 of principal at ~~March~~June 3130, 2025 and December 31, 2024, and no interest expense during the ~~three~~six months ended ~~March~~June 3130, 2025 and interest expense of $23,~~484~~ 775 during the ~~three~~ six months ended ~~March~~June 3130, 2024. The Company made principal payments totaling of $79121,582 during the ~~three~~six months ended ~~March~~June 3130, 2024.

Walter Lubkin Jr. Note

On November 26, 2019, the Company issued a five-year unsecured promissory note in the principal amount of $500,000 to Walter Lubkin Jr. as part of the purchase price for the Coastal Pride acquisition. The note bears interest at the rate of 4% per annum. The note is payable quarterly in an amount equal to the lesser of (i) $25,000 or (ii) 25% of the EBITDA of Coastal Pride, as determined on the first day of each quarter.

For the year ended December 31, 2024, $100,000 of the outstanding principal was paid in cash.

Interest expense for the note totaled approximately $0 and $12,000 during the ~~three~~six months ended ~~March~~June 3130, 2025 and 2024, respectively.

As of ~~March~~June 3130, 2025 and December 31, 2024, the outstanding principal balance on the note totaled $0.

Lind Global Fund II LP notes

2023 Note

On May 30, 2023, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with Lind pursuant to which the Company issued to Lind a secured, two-year, interest free convertible promissory note in the principal amount of $1,200,000 (the “2023 Lind Note”) and a warrant (the “Lind Warrant”) to purchase 8,701 shares of common stock of the Company commencing six months after issuance and exercisable for five years5 ~~years~~ at an exercise price of $122.50 per share. The Lind Warrant includes cashless exercise and full ratchet anti-dilution provisions. In connection with the issuance of the Lind Note and the Lind Warrant, the Company paid Lind a $50,000 commitment fee. The proceeds from the sale of the Note and Warrant are for general working capital purposes.

In connection with the issuance of the 2022 Lind Note, the Company and Lind amended the 2022 Security Agreement to include the new 2023 Lind Note, pursuant to an amended and restated security agreement, dated May 30, 2023, between the Company and Lind.

The Company agreed to file a registration statement with the Securities and Exchange Commission covering the resale of the shares of common stock issuable pursuant to the 2023 Lind Note and Lind Warrant. Lind was also granted piggyback registration rights.

If the Company engages in capital raising transactions, Lind has the right to purchase up to 20% of the new securities for 24 months.

The 2023 Lind Note is convertible into common stock of the Company after the earlier of 90 days from issuance or the date the registration statement is effective, provided that no such conversion may be made that would result in beneficial ownership by Lind and its affiliates of more than 4.99% of the Company’s outstanding shares of common stock. The conversion price of the 2023 Lind Note is equal to the lesser of: (i) $120.00; or (ii) 90% of the lowest single volume-weighted average price during the twenty-trading day period ending on the last trading day immediately preceding the applicable conversion date, subject to customary adjustments. The maximum number of shares of common stock to be issued in connection with the conversion of the 2023 Lind Note and the exercise of the Lind Warrant, in the aggregate, will not, exceed 19.9% of the outstanding shares of common stock of the Company immediately prior to the date of the 2023 Lind Note, in accordance with NASDAQ rules and guidance. Due to the variable conversion price of the 2023 Lind Note, the embedded conversion feature was accounted as a derivative liability. The fair value of the derivative liability at issuance amounting to $264,687, was recorded as a debt discount and amortized over the term of the note.

The 2023 Lind Note contains certain negative covenants, including restricting the Company from certain distributions, stock repurchases, borrowing, sale of assets, loans and exchange offers.

Upon the occurrence of an event of default as described in the 2023 Lind Note, the 2023 Lind Note will become immediately due and payable at a default interest rate of 120% of the then outstanding principal amount of the Lind Note.

The Warrant entitles the Investor to purchase up to 8,701 shares of common stock of the Company during the exercise period commencing on the date that is six months after the issue date (“Exercise Period Commencement”) and ending on the date that is sixty months from the Exercise Period Commencement at an exercise price of $122.50 per share, subject to customary adjustments. The Warrant includes cashless exercise and full ratchet anti-dilution provisions.

On July 27, 2023, the Company, entered into a First Amendment to the Purchase Agreement (the “Purchase Agreement Amendment”) with Lind, which provided for the issuance of further senior convertible promissory notes up to an aggregate principal amount of up to $1,800,000 and the issuance of additional warrants in such amounts as the Company and Lind shall mutually agree.

Pursuant to the Purchase Agreement Amendment, the Company issued to Lind a two-year, interest free convertible promissory note in the principal amount of $300,000 and a warrant to purchase 3,505 shares of common stock of the Company at an exercise price of $67.00 per share for $250,000. In connection with the issuance of the note and the warrant, the Company paid a $12,500 commitment fee. The proceeds from the sale of the note and warrant are for general working capital purposes.

Due to the variable conversion price of the convertible promissory note, pursuant to the Purchase Agreement Amendment, the embedded conversion feature was accounted for as a derivative liability. The fair value of the derivative liability at issuance amounting to $118,984, was recorded as a debt discount and amortized over the term of the note.

On August 3, 2024 the Company and Lind entered into a waiver and acknowledgement agreement.

The Company and Lind previously entered into that certain Securities Purchase Agreement, dated as of May 20, 2023, as amended on July 27, 2023 pursuant to which the Company issued Lind a senior convertible promissory note in the principal amount of $300,000. Each of the Company and Lind acknowledge that the amounts owing under the convertible promissory note as of the filing of the Waiver Agreement is equal to $355,500.

During the ~~three~~six months ended ~~March~~June 3130, 2025, there were no payments to the note principal. The note has a maturity due date of July 27, 2025. As of ~~March~~June 3130, 2025, the outstanding balance on the notes was $55,500, net of debt discount of $153,~~803~~951, and totaling $3951,~~697~~549. As of December 31, 2024, the outstanding balance on the notes was $55,500, net of debt discount of $27,656, and totaling $27,844. For the ~~three~~six months ended ~~March~~June 3130, 2025 and 2024, amortization of debt discounts totaled $1123,~~853~~ 705 and $~~113~~703,~~352~~236, respectively.

Agile Lending, LLC Loans

On January 28, 2025, the Company, and Keeler & Co. (each a “Borrower”) entered into a subordinated business loan and security agreement with Agile and Agile Capital as collateral agent, which provides for a term loan to the Company in the amount of $420,000 which principal and interest (of $176,400) is due on August 15, 2025. Commencing February 7, 2025, the Company is required to make weekly payments of $21,300 until the due date. The loan may be prepaid subject to a prepayment fee. An administrative agent fee of $20,000 was paid on the loan which was recognized as a debt discount and amortized over the term of the loan. In connection with the loan, Agile was issued a subordinated secured promissory note, dated January 28, 2025, in the principal amount of $420,000 which note is secured by all of the Borrowers’ assets, including receivables. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company made principal payments on the ~~loan~~ loan totaling $~~129~~134,000 and no interest payments were made. The outstanding balance on the loan was $~~291~~286,000 as of ~~March~~June 3130, 2025.

1800 Diagonal Notes

On September 9, 2024, the Company issued to Diagonal a convertible promissory note in the principal amount of $179,400 with an original issue discount of $23,400 (the “September Diagonal Note”). The September Diagonal Note has an interest rate of 13% with a one-time interest payment of $23,322 paid upon issuance and a maturity date of June 15, 2025. The proceeds from the sale of the September Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the September Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the September Diagonal Note into shares of the Company’s common stock at a conversion price of 65% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the September Diagonal Note. The Company is required to make monthly payments starting March 15, 2025, until the due date of June 15, 2025. The first payment due March 15, 2025, is $131,769. The monthly payment for April 15, 2025, May 15, 2025, and June 15, 2025, is $23,651. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company made principal payments on the loan totaling $~~146~~179,~~769~~041 of which $15,000 was paid through the issuance of an aggregate of 288,101 share of common stock and no interest payments were made. The outstanding balance on the loan was $~~32,631~~ 359 as of ~~March~~June 3130, 2025.

On October 1, 2024, the Company issued to Diagonal a convertible promissory note in the principal amount of $121,900 with an original issue discount of $15,900 (the “October Diagonal Note”). The October Diagonal Note has an interest rate of 12% with a one-time interest payment of $14,628 paid upon issuance and a maturity date of June 30, 2025. The proceeds from the sale of the October Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the October Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the October Diagonal Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the October Diagonal Note. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company made principal payments on the loan totaling $2740,~~089 and~~633 and interest payments of $34,~~251~~876. The outstanding balance on the loan was $5440,~~178~~633 as of ~~March~~June 3130, 2025.

On December 16, 2024, the Company issued to Diagonal a convertible promissory note in the principal amount of $90,850 with an original issue discount of $11,850 (the “December Diagonal Note”). The December Diagonal Note has an interest rate of 12% with a one-time interest payment of $10,902 paid upon issuance and a maturity date of September 15, 2025. The proceeds from the sale of the December Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the December Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the December Diagonal Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the December Diagonal Note. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company made principal payments on ~~the~~ the loan totaling $3050,~~283~~472 and interest payments of $36,~~634~~057. The outstanding balance on the loan was $6040,~~567~~378 as of ~~March~~June 3130, 2025.

On January 28, 2025, the Company issued to Diagonal a convertible promissory note in the principal amount of $149,650 with an original issue discount of $19,650 (the “January Diagonal Note”). The January Diagonal Note has an interest rate of 13% with a one-time interest payment of $19,454 paid upon issuance and a maturity date of October 30, 2025. The proceeds from the sale of the January Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the January Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the January Diagonal Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the January Diagonal Note. The Company is required to make monthly payments starting July 30, 2025, until the due date of October 30, 2025. The first payment due July 30, 2025, is $109,918. The monthly payment for August 30, 2025, September 30, 2025, and October 30, 2025, is $19,729. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company made no principal and interest payments. The outstanding balance on the loan was $149,650, net of discount of $158,~~283~~733, and totaling $~~134~~140,~~367~~ 917 as of ~~March~~June 3130, 2025.

August 2024 Private Placement Offering

In August, 2024, the Company entered into securities purchase agreements (each a “Securities Purchase Agreement”) with each of Quick Capital, LLC, a Wyoming limited liability company (“Quick Capital”) and Jefferson Street Capital, LLC, a New Jersey limited liability company (“Jefferson”) whereby we issued promissory notes in the aggregate principal amount of $550,000 (the “August Private Placement Offering”).

The Company agreed to issue to Quick Capital and Jefferson up to 39,300 shares of our Common Stock as a “Commitment Fee”.

As part of the August Private Placement Offering, the Company issued two promissory notes each in the principal amount of $275,000 with an original issue discount of $25,000 (the “Private Placement Notes”). The Private Placement Notes have a one-time interest payment of $27,500. Thereafter, any principal amount of interest which is not paid upon maturity will accrue at a rate of the lesser of (i) sixteen percent (16%) per annum, or (ii) the maximum amount permitted by law from the due date thereof until the same is paid. The Private Placement Notes have a maturity date of 10 months after issuance and the proceeds from the notes are for general corporate purposes. The Company agreed to issue to each of Quick Capital and Jefferson 19,650 shares of Common Stock as additional consideration for entering into Private Placement Notes.

The investors have the right, at any time on or following the earlier of (i) the date that any of the shares are registered for resale under a registration statement of the Company or (ii) the date that is six (6) months after the issue date, to convert all or any portion of the then outstanding and unpaid principal and interest into fully paid and non-assessable shares of our Common Stock. The conversion price shall be $1.50, subject to adjustments. We have agreed to reserve a sufficient number of Common Stock (initially, 2,000,000 shares) for issuance upon conversion of the Private Placement Notes in accordance with their terms.

If an event of default occurs under the Private Placement Notes, the investors have the right to convert all amounts outstanding under the notes at any time thereafter into shares of Common Stock at the lesser of (i) the then applicable conversion price under the notes or (ii) the Market Price. “Market Price” shall mean 85% of the lowest VWAP on any trading day during the ten (10) trading days prior to the respective conversion date. “VWAP” means, for any security as of any date, the dollar volume-weighted average price for such security on the principal market during the period beginning at 9:30 a.m., Eastern Standard Time, and ending at 4:00 p.m., Eastern Standard Time, as reported by Quote stream or other similar quotation service provider designated by the investors.

The Company may prepay the Private Placement Notes at any time with fifteen (15) trading days prior written notice (the “Prepayment Notice Period”). During the Prepayment Notice Period, the investor shall have the right to convert all or any portion of the Private Placement Notes pursuant to the terms of the notes, including the amount of the Private Placement Notes to be prepaid. If the Company exercises its right to prepay the notes, the Company shall make payment to the investor of an amount in cash equal to the sum of: (i) 100% multiplied by the principal amount then outstanding plus (ii) accrued and unpaid interest on the principal amount to the Prepayment Notice Date, and (iii) $750 to reimburse the investor for administrative fees.

If the Company delivers a prepayment notice and fails to pay the applicable prepayment amount, the Company shall forever forfeit its right to prepay any part of the Private Placement Notes.

The Private Placement Notes have mandatory monthly payments of $43,200. The initial payments are due on November 9, 2024 and November 12, 2024, respectively.

The Company’s failure to comply with the material terms of the Private Placement Notes will be considered an event of default and the principal sum of the Private Placement Notes will become immediately due and payable at an amount equal to the principal amount then outstanding plus accrued interest (including any default interest) through the date of full repayment multiplied by 135%, as well as all costs, all without demand, presentment or notice, unless expressly waived by the investor.

The investors may assign their rights to any “accredited investor” (as defined in Rule 501(a) of the 1933 Act) in a private transaction or to any of its affiliates without the consent of the Company.

While the Private Placement Notes remain outstanding, we shall not, without the investor’s written consent (i) (a) pay, declare or set apart for such payment, any dividend or other distribution on shares of capital stock other than dividends on shares of Common Stock solely in the form of additional shares of Common Stock or (b) directly or indirectly or through any subsidiary make any other payment or distribution with respect to its capital stock except for distributions pursuant to any shareholders’ rights plan which is approved by a majority of the Company’s disinterested directors, (ii) redeem, repurchase or otherwise acquire (whether for cash or in exchange for property or other securities or otherwise) in any one transaction or series of related transactions any shares of capital stock of the Company or any warrants, rights or options to purchase or acquire any such shares, or repay any indebtedness of the investor (iii) advance any loans made in the ordinary course of business in excess of $100,000, (iv) sell, lease or otherwise dispose of any significant portion of our assets outside the ordinary course of business, and (v) enter into any transaction or arrangement structured in accordance with, based upon, or related or pursuant to, in whole or in part, either Section 3(a)(9) or Section 3(a)(10) of the Securities Act.

In conjunction with the August Private Placement Offering, the Company entered into a registration rights agreement with each of Quick Capital and Jefferson. The Company agreed to file a registration statement with the Securities and Exchange Commission to register the re-sale of the maximum number of shares of Common Stock covered in the August Private Placement Offering within sixty (60) calendar days from the date of execution.

During the ~~three~~six months ended ~~March~~June 3130, 2025, the Company made aggregate principal payments on the Private Placement Notes of $246,454 of which $80,255 was paid through the issuance of an aggregate of 1,000,000 shares of common stock. The outstanding balance on the loan was $111,060 as of ~~March~~June 3130, 2025.

Vehicle Loan

On December 7, 2024, the Company entered into a financing loan in connection with the purchase of a company vehicle. The loan has a principal amount of $69,299, bears interest at an annual rate of 9.34%, and is repayable in monthly installments of $1,450, including principal and interest, over a term of 60 months. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company made principal payments on the loan totaling $7,843 and interest payments of $12,~~107~~357. The outstanding balance on the loan was $61,457 as of ~~March~~June 3130, 2025.

Note 78. Stockholders’ Equity

On January 25, 2024, the Company issued 7,092 shares of common stock to ClearThink, with a fair value of $50,000, as a commitment fee on the term loan.

During February 2024 and March 2024, the Company issued an aggregate of 226,656 shares of common stock in consideration of $836,360 pursuant to a securities purchase agreement, dated May 16, 2023 with ClearThink. Cash proceeds received as of March 31, 2024 were $446,360 and the balance of $390,000 was received in April 2024.

On February 12, 2024, the Company issued 100,000 shares of common stock to be held by The Crone Law Group as Escrow Agent with a fair value of $630,000 in connection with the Option Agreement with Afritex Texas.

On ~~March~~ 11May 22, 2024, the Company issued 1510,000 shares of common stock to ~~Lind~~Hart, aswith ~~partial~~a ~~conversion~~fair value of $6023,~~000~~300, ~~principal~~as ~~pursuant~~a tocommitment ~~the May~~fee ~~2023~~on ~~convertible~~the promissory note.

During the ~~three~~six months ended ~~March~~June 3130, ~~2025~~2024, the Company issued an aggregate of ~~302~~1,~~762~~339,656 shares of common stock toin ~~the~~consideration ~~designee~~of proceeds of ~~ClearThink~~$2,982,415 pursuant to a securities purchase agreement, ~~for~~dated ~~consulting~~May ~~services~~16, ~~provided~~2023 towith ClearThink. Cash proceeds received as of June 30, 2024 were $2,160,765 and the ~~Company~~balance of $821,650 was received in July 2024.

During the six months ended June 30, 2024, the Company issued an aggregate of 441,831 shares of common stock to Lind as partial conversion of $944,900 principal pursuant to the May 2023 convertible promissory note.

During the six months ended June 30, 2024, the Company issued an aggregate of 11,557 shares of common stock to the designee of ClearThink with a fair value of $55,000 for consulting services provided to the Company.

During the six months ended June 30, 2025, the Company issued an aggregate of 877,509 shares of common stock to the designee of ClearThink for consulting services provided to the Company.

On January 14, 2025, the Company issued 480,000 shares of common stock to each of Nubar Herian and John Keeler, 960,000 shares of common stock to each of Timothy McLellan and Trond Ringstad, and 1,440,000 shares of common stock to Jeffrey Guzy, for serving as directors of the Company.

On March 11, 2025, the Company issued 350,000 shares of common stock in consideration of proceeds of $19,950 pursuant to a securities purchase agreement, dated May 16, 2023 with ClearThink.

On March 12, 2025, the Company issued 288,101 shares of common stock to Diagonal as partial conversion of $15,000 principal pursuant to the convertible promissory note.

During the ~~three~~six months ended ~~March~~June 3130, 2025, the Company issued an aggregate of 750,000 shares of common stock to Quick Capital as partial ~~conversion~~ conversion of $57,673 principal pursuant to the convertible promissory note.

During the ~~three~~six months ended ~~March~~June 3130, 2025, the Company issued an aggregate of 406,484 shares of common stock to Jefferson as partial conversion of $32,583 principal and accrued interest pursuant to the convertible promissory note.

Note 89. Options

The following table represents option activity for the ~~three~~six months ended ~~March~~June 3130, 2025:

Schedule of Option Activity

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2024		4,744	$	1,532.26		3.34
Exercisable – December 31, 2024		4,076	$	1532.26		3.61	$	-
Granted		-	$	-
Forfeited		1,~~058~~353	$	-
Vested		3,~~632~~344
Outstanding – March 31, 2025		3,686	$	1,998.13		3.58
Outstanding – June 30, 2025		3,391	$	1,997.97		3.31
Exercisable – March 31, 2025		3,632	$	1,998.52		3.60	$	-
Exercisable – June 30, 2025		3,344	$	1,998.24		3.33	$	-

For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company recognized a net credit to stock compensation expense of $52,~~627~~480 due to options forfeitures.

~~Note~~The following table represents option activity for 9.the ~~Warrants~~six months ended June 30, 2024:

The following table represents warrant activity for the three months ended March 31, 2025:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2023		6,331	$	1,555.52		3.80	$	-
Exercisable – December 31, 2023		4,398	$	1,555.52		4.27	$	-
Granted		-	$	-
Forfeited		896	$	-
Expired		500	$	-
Vested		4,078	$	-
Outstanding – June 30, 2024		4,935	$	1,537.86		3.88	$	-
Exercisable – June 30, 2024		4,078	$	1,537.86		4.22	$	-

For the six months ended June 30, 2024, the Company recognized a net credit to stock compensation expense of $5,623 due to options forfeitures.

Note 10. Warrants

The following table represents warrant activity for the six months ended June 30, 2025:

Schedule of Warrant Activity

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2024		12,205	$	106.71		3.96
Exercisable – December 31, 2024		12,205	$	106.71		3.96	$	-
Granted		-	$	-
Exercised		-	$	-
Forfeited or Expired		-	$	-
Outstanding – March 31, 2025		12,205	$	106.71		3.72
Outstanding – June 30, 2025		12,205	$	106.71		3.47
Exercisable – March 31, 2025		12,205	$	106.71		3.72	$	-
Exercisable – June 30, 2025		12,205	$	106.71		3.47	$	-

~~On May~~The ~~30,~~following ~~2023,~~table inrepresents ~~connection~~warrant ~~with~~activity ~~the issuance of the $1,200,000 promissory~~for ~~note to Lind pursuant to a securities purchase agreement,~~ the ~~Company issued Lind a five-yearfive years warrant exercisable~~ six months ~~from~~ended ~~the~~June ~~date of issuance to purchase 8~~30,~~701 shares~~ of common stock at an exercise price of $122.50 per share. The warrant provides for cashless exercise and full ratchet anti-dilution provisions. The fair value of the warrants of $381,538 was recorded as a discount to the 2023 Lind Note and classified as liabilities.2024:

On July 27, 2023, in connection with the issuance of the $300,000 promissory note to Lind pursuant to the Purchase Agreement Amendment, the Company issued Lind a five-year5 warrant exercisable six months from the date of issuance to purchase 3,505 shares of common stock at an exercise price of $67.00 per share. The warrant provides for cashless exercise and full ratchet anti-dilution provisions. The fair value of the warrants of $72,208 was recorded as a discount to the 2023 Purchase Agreement Amendment and classified as a liability.

	Number of Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2023		14,619		$	601.78		4.20
Exercisable – December 31, 2023		11,114		$	770.50		5.52	$	-
Granted		-		$	-
Exercised		-		$	-
Forfeited or Expired		(2,144	)	$	-
Outstanding – June 30, 2024		12,475		$	161.07		4.30
Exercisable – June 30, 2024		12,475		$	161.07		4.30	$	-

On May 30, 2023, in connection with the issuance of the $1,200,000 promissory note to Lind pursuant to a securities purchase agreement, the Company issued Lind a 5 five-year warrant exercisable six months from the date of issuance to purchase 8,701 shares of common stock at an exercise price of $122.50 per share. The warrant provides for cashless exercise and full ratchet anti-dilution provisions. The fair value of the warrants of $381,538 was recorded as a discount to the 2023 Lind Note and classified as liabilities.

On July 27, 2023, in connection with the issuance of the $300,000 promissory note to Lind pursuant to the Purchase Agreement Amendment, the Company issued Lind a 5 five-year warrant exercisable six months from the date of issuance to purchase 3,505 shares of common stock at an exercise price of $67.00 per share. The warrant provides for cashless exercise and full ratchet anti-dilution provisions. The fair value of the warrants of $72,208 was recorded as a discount to the 2023 Purchase Agreement Amendment and classified as a liability.

On September 11, 2023, in connection with the underwritten public offering, the Company issued 5 five-~~year5~~year Series A-1 warrants to purchase up to 214,823 shares of common stock which warrants are exercisable upon stockholder approval at an exercise price of $23.28 per share. Since the exercise of these warrants is contingent upon stockholder approval, which stockholder approval has not been obtained, such warrants were not considered as outstanding as of ~~March~~June 3130, ~~2024~~2025.

On September 11, 2023, in connection with the underwritten public offering, the Company issued 18 eighteen-~~month18~~month Series A-2 warrants to purchase up to 214,823 shares of common stock which warrants are exercisable upon stockholder approval at an exercise price of $23.28 per share. Since the exercise of these warrants is contingent upon stockholder approval, which stockholder approval has not been obtained, such warrants were not considered as outstanding as of ~~March~~June 3130, ~~2024~~2025.

There was no warrant activity for the ~~three~~six months ended ~~March~~June 3130, 2025 and 2024.

Note 1011. Commitment and Contingencies

Office lease

On January 1, 2022, the Company entered into a verbal month-to-month lease agreement for its executive offices with an unrelated third party and paid $1734,~~400~~800 on the lease for the ~~three~~six months ended ~~March~~June 3130, 2024. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company paid $1325,800 under this lease.

Coastal Pride leased approximately 1,100 square feet of office space in Beaufort, South Carolina which consists of a lease with a related party for $1,000 per month that expires in October 2024. In August 2024, the lease was terminated aseffective ~~of August 31, 2024~~immediately.

Coastal Pride also leased a 9,050 square foot facility for $1,000 per month from Gault, an unrelated third party, for its soft-shell crab operations in Beaufort, South Carolina under a 1 one-~~year1~~year lease that expired in February 2023. On February 3, 2023, the lease was renewed for $1,500 per month until February 2024. On February 3, 2024, the Coastal Pride entered into a verbal month-to-month lease agreement with Gault for $1,500 ~~per~~ per month. For the ~~three~~six months ended ~~March~~June 3130, 2025, Coastal Pride paid $49,~~500~~ 000 on the lease.

The offices and facility of TOBC are located in Nanaimo, British Columbia, Canada and are on land which was leased to TOBC for approximately $2,500 per month plus taxes, from Steve and Janet Atkinson, a related party and the former TOBC owners. On April 1, 2022, TOBC entered into a new five-year lease with Steve and Janet Atkinson for CAD$2,590 per month plus taxes, and an additional five-year lease with Kathryn Atkinson for CAD$2,370 per month plus taxes. Both leases are renewable for two additional five-year terms. The Company evaluated the lease terms at inception and has not determined whether it will exercise the renewal options.

Rental and equipment lease expenses were approximately $1122,~~400~~ 900 for related party and $1638,~~500~~200 for non-related party for the ~~three~~six months ended June ~~March 31~~30, 2025. For the ~~three~~six months ended ~~March~~June 3130, 2024, rental lease expenses was approximately $1526,~~000~~700 for related party and $2750,~~600~~ 200 for non-related party.

Note 1112. Subsequent Events

Shares issuances

On ~~April~~July 117, 2025, ~~May 1, 2025, and June 1, 2025,~~ the Company issued ~~an aggregate of 574~~470,~~747~~957 shares of common stock to ~~the~~Diagonal ~~designee~~as ofpartial ~~ClearThink for~~conversion ~~consulting~~of ~~services~~$15,000 ~~provided~~principal pursuant to the convertible ~~Company~~promissory note.

On July 22, 2025, the Company issued 261,437 shares of common stock to Jefferson as partial conversion of $9,250 accrued interest pursuant to the convertible promissory note.

1800 Diagonal Notes

On July 1, 2025, the Company entered into default on the September Diagonal Note and October Diagonal Note under the terms of a convertible promissory note. Refer to Note 7 for additional information regarding the nature and financial impact of this default.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

The following management’s discussion and analysis should be read in conjunction with the financial statements and the related notes thereto contained in this Quarterly Report. The management’s discussion and analysis contain forward-looking statements, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties, including those under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on April 1, 2025, as updated in subsequent filings we have made with the SEC that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Quarterly Report.

Basis of Presentation

The following discussion highlights our results of operations and the principal factors that have affected our financial condition as well as our liquidity and capital resources for the periods described and provides information that management believes is relevant for an assessment and understanding of the statements of financial condition and results of operations presented herein. The following discussion and analysis are based on our unaudited financial statements contained in this Quarterly Report, which we have prepared in accordance with United States generally accepted accounting principles. You should read the discussion and analysis together with such financial statements and the related notes thereto.

Overview

We are an international seafood company that imports, packages and sells refrigerated pasteurized crab meat, and other premium seafood products. Our current source of revenue is from importing blue and red swimming crab meat primarily from South East Asia and distributing it in the United States and Canada under several brand names such as Blue Star, Oceanica, Pacifika, Crab & Go, First Choice, Good Stuff and Coastal Pride Fresh, as well as soft shell crab in the United States and steelhead salmon and rainbow trout fingerlings produced under the brand name Little Cedar Farms for distribution in Canada. The crab meat which we import is processed in six out of the ten plants available throughout Southeast Asia. Our suppliers are primarily via co-packing relationships, including two affiliated suppliers. We sell primarily to food service distributors. We also sell our products to wholesalers, retail establishments and seafood distributors.

Recent Events

Resignation of Chief Operating Officer and Director

On June 2, 2025, Miozotis Ponce, the Company’s Operating Officer, notified the Company of her resignation as Chief Operating Officer, effective June 30, 2025.

Results of Operations

The following discussion and analysis of financial condition and results of operations of the Company is based upon, and should be read in conjunction with, the financial statements and accompanying notes elsewhere in this Quarterly Report.

Three months ended ~~March~~June 3130, 2025 and 2024

Net Revenue. Revenue for the three months ended ~~March~~June 3130, 2025 ~~decreased~~increased 984.36% to $~~960~~1,~~758~~172,340 as compared to $1635,~~059,355~~018 for the three ~~months~~ months ended ~~March~~June 3130, 2024 as a result of aan ~~decrease~~increase in ~~poundage~~inventory items sold along with increase in price during the three months ended ~~March~~June 3130, 2025.

Cost of Goods Sold. Cost of goods sold for the three months ended ~~March~~June 3130, 2025 ~~decreased~~increased to $~~869~~919,~~114~~650 as compared to $1587,~~098,989~~516 for the three months ended ~~March~~June 3130, 2024. This ~~decrease~~increase is attributable to ~~the~~cost ~~decrease~~ in ~~poundage sold in~~ the ~~cost of goods and no~~ inventory ~~reserve~~items ~~recorded~~sold ~~during~~along ~~the~~with ~~three~~increase ~~months~~in ~~ended~~items ~~March 31, 2025 compared to the three months ended March 31,2024~~sold.

Gross Profit. Gross profit for the three months ended ~~March~~June 3130, 2025 increased to $91252,~~644~~690 as compared to gross ~~loss~~profit of $3947,~~634~~502 in the ~~three~~ three months ~~March~~ended 31June 30, 2024. This increase nois ~~inventory~~attributable ~~reserve recorded during the three months ended March 31, 2025 compared~~ to the ~~three~~increase ~~months~~in ~~ended March 31,2024~~sales.

Commissions Expense. Commissions expense ~~decreased~~increased to $0460 for the three months ended ~~March~~June 3130, 2025 from $~~4,221~~0 for the three months ended ~~March 31,~~June 30, 2024. This ~~decrease~~increase was due to no commissionable revenues for the three months ended ~~March~~June 3130, ~~2025~~2024.

Salaries and Wages Expense. Salaries and wages expense increased to $~~408~~333,~~296~~226 for the three months ended ~~March~~June 3130, 2025 as compared to $~~301~~291,~~790~~231 for the three months ended ~~March~~June 3130, 2024. This increase is mainly attributable to the ~~accrual~~increase ofin ~~directors~~gross ~~stock compensation~~wages.

~~Depreciation and~~Director ~~Amortization~~Compensation. ~~Depreciation~~Director compensation ~~and amortization expense~~ increased to $6138,~~386~~012 for the three months ended ~~March~~June 3125, 2025 as compared to $14,~~299~~217 for the three months ended ~~March~~June 3130, 2024. This increase is mainly attributable to ~~higher~~the ~~depreciation~~accrual ~~due~~of todirector ~~purchases~~compensation offor ~~fixed~~year-end ~~assets~~stock issuances.

~~Other~~Depreciation ~~Operating~~and ~~Expense~~Amortization. ~~Other~~Depreciation ~~operating~~and amortization expense ~~decreased~~increased to $~~648~~6,~~483~~932 for the three months ended ~~March~~June 3130, 2025 ~~from~~as compared to $~~681~~1,~~611~~377 for the three months ended ~~March~~June 3130, 2024. This ~~decrease~~increase is ~~mainly~~ attributable to ~~legal~~higher ~~and~~depreciation ~~professional~~due ~~expenses~~to ~~related~~depreciable topurchases of ~~our~~fixed ~~business~~assets ~~operations~~during the three months ended June 30, 2025.

Other ~~Income~~Operating Expense. Other ~~income~~operating ~~increased~~expense decreased to $267,935 for the three months ended ~~March~~June 3130, 2025 ~~to $6,615~~ from $1634,~~535~~190 for the three months ended ~~March~~June 3130, 2024. This ~~increase~~decrease is mainly attributable to ~~other~~expenses ~~non-operating~~like ~~income~~legal ~~recognized~~and ~~during~~professional ~~the~~fees ~~period~~and storage warehouse.

~~Change~~Other ~~in Fair Value of Derivatives and Warrants Liabilities~~Income. ~~Change~~Other inincome ~~fair value of derivatives and warrants liabilities~~ decreased ~~to $14,090~~ for the three months ended ~~March~~June 3130, 2025 to an expense balance of $1,866 from $8248,~~636~~127 for the three months ended ~~March~~June 3130, 2024. This decrease is mainly attributable to ~~the~~less ~~fair~~other ~~value~~non-operating ~~measurement~~income ~~for~~recognized ~~the~~during ~~derivative liability for~~ the ~~three months ended March 31, 2025~~period.

Loss on Settlement of Debt. Loss on settlement of debt ~~increased~~was to $~~41,066~~0 for the three months ended ~~March~~June 3130, 2025 ~~from~~and $0June ~~for the three months ended March 31~~30, 2024. ~~The increase is attributable to the Jefferson and Quick Capital payments during the three months ended March 31, 2025.~~

~~Interest~~Change ~~Expense~~in Fair Value of Derivative and Warrant Liabilities. ~~Interest~~Change ~~expense~~in ~~decreased~~fair value of derivative and warrant liabilities increased to a gain of $~~208~~15,~~048~~846 for the three months ended ~~March~~June 3130, 2025 from a loss of $~~335~~327,~~067~~122 for the three months ended ~~March~~ 31June 30, 2024. The ~~decrease~~increase is attributable to the ~~decrease~~fair invalue ~~amortization~~measurement offor ~~debt~~the ~~discount~~derivative liability and ~~interest~~warrant ~~paid~~liability ~~and~~for ~~accrued~~the onthree ~~the~~months ~~notes~~ended June 30, 2025.

~~Net~~Interest ~~Loss~~Expense. ~~Net~~Interest ~~loss~~expense ~~was~~decreased to $1171,~~199,930~~923 for the three months ended ~~March~~June 3130, 2025 asfrom ~~compared to~~ $1871,~~279,451~~249 for the three months ended ~~March~~ 31June 30, 2024. The decrease ~~in net loss~~ is ~~primarily~~ attributable to the ~~change~~decrease in ~~fair~~amortization ~~value~~ of ~~derivative~~debt discount and ~~warrant~~interest ~~liabilities~~paid and accrued on the ~~interest~~ ~~expense~~notes.

Net Loss. Net loss was $651,818 for the three months ended June 30, 2025 as compared to $2,033,757 for the three months ended June 30, 2024. The decrease in net loss is primarily attributable to the change in fair value of derivative and warrant liabilities and the interest expense.

Six months ended June 30, 2025 and 2024

Net Revenue. Revenue for the six months ended June 30, 2025 increased 25.9% to $2,133,098 as compared to $1,694,373 for the six months ended June 30, 2024 as a result of increase in inventory items sold along with increase in price during the six months ended June 30, 2025.

Cost of Goods Sold. Cost of goods sold for the six months ended June 30, 2025 increased to $1,788,764 as compared to $1,686,505 for the six months ended June 30, 2025. This increase is attributable to cost in the inventory items sold along with increase in items sold.

Gross Profit. Gross profit for the six months ended June 30, 2025 increased to $344,334 as compared to gross profit of $7,868 in the six months ended June 30, 2024. This increase is attributable to increase in sales.

Commissions Expense. Commissions expense decreased to $460 for the six months ended June 30, 2025 from $4,221 for the six months ended June 30, 2024. This decrease was due to commissionable revenues for the six months ended June 30, 2025.

Salaries and Wages Expense. Salaries and wages expense increased to $603,510 for the six months ended June 30, 2025 as compared to $598,912 for the six months ended June 30, 2024. This increase is mainly attributable to the accrual of director compensation for year-end stock issuances.

Director Compensation. Director compensation increased to $276,024 for the three months ended June 25, 2025 as compared to a credit balance of $1,673 for the six months ended June 30, 2024. This increase is mainly attributable to the accrual of director compensation for year-end stock issuances.

Depreciation and Amortization. Depreciation and amortization expense increased to $13,318 for the six months ended June 30, 2025 as compared to $2,676 for the six months ended June 30, 2024. This increase is attributable to higher depreciation due to depreciable purchases of fixed assets during the six months ended June 30, 2025.

Other Operating Expense. Other operating expense decreased to $916,418 for the six months ended June 30, 2025 from $1,315,801 for the six months ended June 30, 2024. This decrease is mainly attributable to expenses like legal and professional fees and storage warehouse.

Other Income. Other income decreased for the six months ended June 30, 2025 to $4,749 from $49,662 for the six months ended June 30, 2024. This decrease is mainly attributable to less other non-operating income recognized during the period.

Loss on Settlement of Debt. Loss on settlement of debt increased to $41,066 for the six months ended June 30, 2025 from $0 for the six months ended June 30, 2024. The increase is caused by the Securities Purchase Agreement notes repayments during the six months ended June 30, 2025.

Change in Fair Value of Derivative and Warrant Liabilities. Change in fair value and derivative and warrant liabilities increased to a gain of $29,936 for the six months ended June 30, 2025 from a loss of $244,486 for the six months ended June 30, 2024. The increase is attributable to the fair value measurement for the derivative liability and warrant liability for the six months ended June 30, 2025.

Interest Expense. Interest expense decreased to $379,971 for the six months ended June 30, 2025 from $1,206,316 for the six months ended June 30, 2024. The decrease is attributable to the decrease in amortization of debt discount and interest paid and accrued on the notes.

Net Loss. Net loss was $1,851,748 for the six months ended June 30, 2025 as compared to $3,313,209 for the six months ended June 30, 2024. The decrease in net loss is primarily attributable to the change in fair value of derivative and warrant liabilities and the interest expense.

Liquidity and Capital Resources

The Company had cash of $2345,~~049~~976 as of ~~March~~June 3130, 2025. AtAs ~~March~~of 31June 30, 2025, the Company had a working capital deficit of $~~687~~1,~~321~~553,621 and the Company’s primary sources of liquidity consisted of inventory of $~~342~~248,~~825~~995 and accounts receivable of $~~455~~344,~~518~~309.

The Company has historically financed its operations through the cash flow generated from operations, capital investment, notes payable and a working capital line of credit.

Cash (Used in) Operating Activities. Cash used in operating activities during the ~~three~~six months ended ~~March~~June 3130, 2025 was $~~392~~188,~~550~~245 as ~~compared~~ compared to cash used in operating activities of $~~679~~2,~~928~~639,077 for the ~~three~~six months ended ~~March~~June 3130, 2024. The decrease is primarily attributable to decrease in inventory of $~~571~~421,~~008~~973 and decrease in accounts receivable of $319,177, offset by the increase in other current assets of $~~622~~2,~~820~~068,264 and increase in payables and accruals of $~~629~~611,~~617~~222 for the ~~three~~six months ended ~~March~~June 3130, 2025 compared with the ~~three~~six months ended June ~~March 31~~30, 2024.

Cash (Used in) Investing Activities. Cash used in investing activities for the ~~three~~six months ended ~~March~~June 3130, 2025 was $9,914 as compared to to cash used in investing activities of $2357,~~146~~797 for the ~~three~~six months ended ~~March~~June 3130, 2024. The decrease was mainly attributable to a ~~decrease~~ decrease in the purchases of fixed assets for the ~~three~~six months ended ~~March~~June 3130, 2025 compared to the purchases of fixed assets for the ~~three~~ ~~months~~six months ended ~~March~~June 3130, 2024.

Cash Provided by Financing Activities. Cash provided by financing activities for the ~~three~~six months ended ~~March~~June 3130, 2025 was $809,~~167~~162 as ~~compared~~ compared to cash provided by financing activities of $~~622~~2,~~626~~650,048 for the ~~three~~six months ended ~~March~~June 3130, 2024. The ~~increase~~decrease is mainly attributable ~~due~~ due to the ~~increased~~netted decrease in repayments and proceeds of short-term loans and less proceeds from common stock offering during the ~~three~~six months ended ~~March 31~~June 30, 2025.

2526

Lind Global Fund II LP investment

On May 30, 2023, the Company entered into a securities purchase agreement with Lind pursuant to which the Company issued to Lind a secured, two-year, interest free convertible promissory note in the principal amount of $1,200,000 (the “Lind Note”) and a warrant (the “Lind Warrant”) to purchase 8,701 shares of common stock of the Company commencing six months after issuance and exercisable for five years at an exercise price of $122.50 per share, for the aggregate funding amount of $1,000,000. The Lind Warrant includes cashless exercise and full ratchet anti-dilution provisions. In connection with the issuance of the Lind Note and the Lind Warrant, the Company paid Lind a $50,000 commitment fee. The proceeds from the sale of the Note and Warrant are for general working capital purposes.

On July 27, 2023, the Company, entered into a First Amendment to the securities purchase agreement (the “Purchase Agreement Amendment”) with Lind, pursuant to which the Company amended the securities purchase agreement, entered into with Lind as of May 30, 2023 in order to permit the issuance of further senior convertible promissory notes in the aggregate principal amount of up to $1,800,000 and warrants in such aggregate amount as the Company and Lind shall mutually agree.

Pursuant to the Purchase Agreement Amendment, the Company issued to Lind a two-year, interest free convertible promissory note in the principal amount of $300,000 and a warrant to purchase 3,505 shares of common stock of the Company, for the aggregate amount of $250,000. In connection with the issuance of the note and the warrant, the Company paid a $12,500 commitment fee. The proceeds from the sale of the note and warrant are for general working capital purposes.

On August 3, 2024 the Company and Lind entered into a waiver and acknowledgement agreement.

During the ~~three~~six months ended ~~March~~June 3130, 2025, there were no payments to the note principal. The note has a maturity due date of July 27, 2025. As of ~~March~~June 3130, 2025, the outstanding balance on the notes was $55,500, net of debt discount of $153,~~803~~951, and totaling $3951,~~697~~549. As of December 31, 2024, the outstanding balance on the notes was $55,500, net of debt discount of $27,656, and totaling $27,844. For the six ~~three~~ months ended ~~March~~June 3130, 2025 and 2024, amortization of debt discounts totaled $1123,~~853~~705 and $~~113~~703,~~352~~236, respectively.

Agile Lending, LLC Loans

On January 28, 2025, the Company entered into a subordinated business loan and security agreement with Agile and Agile Capital as collateral agent, which provides for a term loan to the Company in the amount of $420,000 which principal and interest (of $176,400) and has a maturity date of August 15, 2025. Commencing February 7, 2025, the Company is required to make weekly payments of $21,300 until the maturity date. The loan may be prepaid subject to a prepayment fee. Administrative agent fee of $20,000 was paid on the loan which was recognized as a debt discount and amortized over the term of the loan. In connection with the loan, Agile was issued a subordinated secured promissory note, dated January 28, 2025, in the principal amount of $420,000 which note is secured by all of the Borrowers’ assets, including receivables. For the ~~three~~six months ended ~~March~~June 3130, 2025, the Company made principal payments on the loan totaling $~~129~~134,000 and no interest payments were made. The outstanding balance on the loan was $~~291~~286,000 as of ~~March~~June 3130, 2025.

1800 Diagonal Notes

On September 9, 2024, the Company issued to Diagonal a convertible promissory note in the principal amount of $179,400 with an original issue discount of $23,400 (the “September Diagonal Note”). The September Diagonal Note has an interest rate of 13% with a one-time interest payment of $23,322 paid upon issuance and a maturity date of June 15, 2025. The proceeds from the sale of the September Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the September Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the September Diagonal Note into shares of the Company’s common stock at a conversion price of 65% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the September Diagonal Note. The Company is required to make monthly payments starting March 15, 2025, until the due date of June 15, 2025. The first payment due March 15, 2025, is $131,769. The monthly payment for April 15, 2025, May 15, 2025, and June 15, 2025, is $23,651. For the three months ended March 31, 2025, the Company made principal payments on the loan totaling $146,769 of which $15,000 was paid through the issuance of an aggregate of 288,101 share of common stock and no interest payments were made. The outstanding balance on the loan was $32,631 as of March 31, 2025.

On October 1, 2024, the Company issued to Diagonal a convertible promissory note in the principal amount of $121,900 with an original issue discount of $15,900 (the “October Diagonal Note”). The October Diagonal Note has an interest rate of 12% with a one-time interest payment of $14,628 paid upon issuance and a maturity date of June 30, 2025. The proceeds from the sale of the October Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the October Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the October Diagonal Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the October Diagonal Note. For the three months ended March 31, 2025, the Company made principal payments on the loan totaling $27,089 and interest payments of $3,251. The outstanding balance on the loan was $54,178 as of March 31, 2025.

On December 16, 2024, the Company issued to Diagonal a convertible promissory note in the principal amount of $90,850 with an original issue discount of $11,850 (the “December Diagonal Note”). The December Diagonal Note has an interest rate of 12% with a one-time interest payment of $10,902 paid upon issuance and a maturity date of September 15, 2025. The proceeds from the sale of the December Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the December Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the December Diagonal Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the December Diagonal Note. For the three months ended March 31, 2025, the Company made principal payments on the loan totaling $30,283 and interest payments of $3,634. The outstanding balance on the loan was $60,567 as of March 31, 2025.

On1800 ~~January 28, 2025, the Company issued to~~ Diagonal a convertible promissory note in the principal amount of $149,650 with an original issue discount of $19,650 (the “January Diagonal Note”). The January Diagonal Note has an interest rate of 13% with a one-time interest payment of $19,454 paid upon issuance and a maturity date of October 30, 2025. The proceeds from the sale of the January Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the January Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the January Diagonal Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the January Diagonal Note. For the three months ended March 31, 2025, the Company made no principal and interest payments. The outstanding balance on the loan was $149,650, net of discount of $15,283, and totaling $134,367 as of March 31, 2025.Notes

On September 9, 2024, the Company issued to Diagonal a convertible promissory note in the principal amount of $179,400 with an original issue discount of $23,400 (the “September Diagonal Note”). The September Diagonal Note has an interest rate of 13% with a one-time interest payment of $23,322 paid upon issuance and a maturity date of June 15, 2025. The proceeds from the sale of the September Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the September Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the September Diagonal Note into shares of the Company’s common stock at a conversion price of 65% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the September Diagonal Note. The Company is required to make monthly payments starting March 15, 2025, until the due date of June 15, 2025. The first payment due March 15, 2025, is $131,769. The monthly payment for April 15, 2025, May 15, 2025, and June 15, 2025, is $23,651. For the six months ended June 30, 2025, the Company made principal payments on the loan totaling $179,041 of which $15,000 was paid through the issuance of an aggregate of 288,101 share of common stock and no interest payments were made. The outstanding balance on the loan was $359 as of June 30, 2025.

On October 1, 2024, the Company issued to Diagonal a convertible promissory note in the principal amount of $121,900 with an original issue discount of $15,900 (the “October Diagonal Note”). The October Diagonal Note has an interest rate of 12% with a one-time interest payment of $14,628 paid upon issuance and a maturity date of June 30, 2025. The proceeds from the sale of the October Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the October Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the October Diagonal Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the October Diagonal Note. For the six months ended June 30, 2025, the Company made principal payments on the loan totaling $40,633 and interest payments of $4,876. The outstanding balance on the loan was $40,633 as of June 30, 2025.

On December 16, 2024, the Company issued to Diagonal a convertible promissory note in the principal amount of $90,850 with an original issue discount of $11,850 (the “December Diagonal Note”). The December Diagonal Note has an interest rate of 12% with a one-time interest payment of $10,902 paid upon issuance and a maturity date of September 15, 2025. The proceeds from the sale of the December Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the December Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the December Diagonal Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the December Diagonal Note. For the six months ended June 30, 2025, the Company made principal payments on the loan totaling $50,472 and interest payments of $6,057. The outstanding balance on the loan was $40,378 as of June 30, 2025.

On January 28, 2025, the Company issued to Diagonal a convertible promissory note in the principal amount of $149,650 with an original issue discount of $19,650 (the “January Diagonal Note”). The January Diagonal Note has an interest rate of 13% with a one-time interest payment of $19,454 paid upon issuance and a maturity date of October 30, 2025. The proceeds from the sale of the January Diagonal Note are for general working capital. Upon the occurrence of an event of default as described in the January Diagonal Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the January Diagonal Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without Diagonal’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the January Diagonal Note. The Company is required to make monthly payments starting July 30, 2025, until the due date of October 30, 2025. The first payment due July 30, 2025, is $109,918. The monthly payment for August 30, 2025, September 30, 2025, and October 30, 2025, is $19,729. For the six months ended June 30, 2025, the Company made no principal and interest payments. The outstanding balance on the loan was $149,650, net of discount of $8,733, and totaling $140,917 as of June 30, 2025.

August 2024 Private Placement Offering

The Company agreed to issue to Quick Capital and Jefferson up to 39,300 shares of our Common Stock as a “Commitment Fee”.

If the Company delivers a prepayment notice and fails to pay the applicable prepayment amount, the Company shall forever forfeit its right to prepay any part of the Private Placement Notes.

2829

The Private Placement Notes have mandatory monthly payments of $43,200. The initial payments are due on November 9, 2024 and November 12, 2024, respectively.

Off-Balance Sheet Arrangements

We currently have no off-balance sheet arrangements.

2930

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, as of March 31, 2025, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended. Based on this evaluation our principal executive officer and principal financial officer ~~have~~has concluded that based on the material weaknesses discussed below our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed by us in reports filed or submitted under the Securities Exchange Act were recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that our disclosure controls are not effectively designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act is accumulated and communicated to management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

The matters involving internal controls and procedures that our management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were:

● inadequate control over the monitoring of inventory maintained in the Company’s third-party warehouse;

● ineffective controls over the Company’s financial close and reporting process; and

● inadequate segregation of duties consistent with control objectives, including lack of personnel resources and technical accounting expertise within the accounting function of the Company.

Management’s Remediation Initiatives

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we plan to further initiate, the following measures, subject to the availability of required resources:

● We plan to create a position to segregate duties consistent with control objectives and hire personnel resources with technical accounting expertise within the accounting function; and

● We plan to create an internal control framework that will address financial close and reporting process, among other procedures.

Changes in Internal Control over Financial Reporting

During the period covered by this Quarterly Report, there were no changes in our internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

3031

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

There are no material pending legal proceedings to which we are a party or in which any director, officer or affiliate of ours, any owner of record or beneficially of more than 5% of any class of our voting securities, or security holder is a party adverse to us or has a material interest adverse to us.

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On January 13, 2025 and February 24, 2025, the Company issued an aggregate of 750,000 shares of common stock to Quick Capital as partial conversion of $57,673 principal pursuant to the convertible promissory note.

January 17, 2025, ~~and~~ February 25, 2025, and July 22, 2025, the Company issued an aggregate of ~~406~~667,~~484~~921 shares of common stock to Jefferson as partial conversion of $3241,~~583~~833 principial and accrued interest pursuant to the convertible promissory note.

On March 12, 2025, and July 17, 2025, the Company issued ~~288~~759,~~101~~058 shares of common stock to Diagonal as partial conversion of $1530,000 principal pursuant to the convertible promissory note.

During the ~~three~~six months ended ~~March~~June 3130, 2025, the Company issued an aggregate of ~~302~~877,~~762~~509 shares of common stock to the designee of ClearThink ~~for~~ for consulting services provided to the Company.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

~~None~~As of August 15, 2025, the Company was in default under two unsecured convertible promissory notes. The total amount in default, inclusive of unpaid interest and contractual default interest, is approximately $98,471, representing approximately 6.7% of the Company’s total consolidated assets as of June 30, 2025. The note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, Diagonal will have the right to convert all or any part of the outstanding and unpaid amount of the September and October Diagonal Note into shares of the Company’s common stock at a conversion price of 65% and 75% of the market price as described in the note, respectively.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

During the ~~three~~six months ended ~~March~~June 3130, 2025, none of the Company’s directors or officers adopted or terminated any contract, instruction, or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any non-Rule 10b5-1 trading arrangements as defined in Item 408(a) of Regulation S-K.

ITEM 6. EXHIBITS

Exhibit No.		Description

31.1		Certification of Principal Executive Officer and Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1		Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

3132

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	BLUE STAR FOODS CORP.
Dated: July 14, 2025	By:	/s/ John Keeler
Dated: August 18, 2025	By:	/s/ John Keeler
	Name:	John Keeler
	Title:	Executive Chairman and Chief Executive Officer (Principal Executive Officer, Principal Financial Officer and Accounting Officer)

3233

Filing Compare · Blue Star Foods Corp.